PMID- 24725030 OWN - NLM STAT- MEDLINE DCOM- 20150525 LR - 20181202 IS - 1432-2277 (Electronic) IS - 0934-0874 (Linking) VI - 27 IP - 8 DP - 2014 Aug TI - Human leukocyte antigen matching in heart transplantation: systematic review and meta-analysis. PG - 793-804 LID - 10.1111/tri.12335 [doi] AB - Allocation of donors with regard to human leukocyte antigen (HLA) is controversial in heart transplantation. This paper is a systematic review and meta-analysis of the available evidence. PubMed, Embase, and the Cochrane Library were searched systematically for studies that addressed the effects of HLA matching on outcome after heart transplantation. Fifty-seven studies met the eligibility criteria. 34 studies had graft rejection as outcome, with 26 of the studies reporting a significant reduction in graft rejection with increasing degree of HLA matching. Thirteen of 18 articles that reported on graft failure found that it decreased significantly with increasing HLA match. Two multicenter studies and nine single-center studies provided sufficient data to provide summary estimates at 12 months. Pooled comparisons showed that graft survival increased with fewer HLA-DR mismatches [0-1 vs. 2 mismatches: risk ratio (RR) = 1.09 (95% confidence interval (CI): 1.01-1.19; P = 0.04)]. Having fewer HLA-DR mismatches (0-1 vs. 2) reduced the incidence of acute rejection [(RR = 0.81 (0.66-0.99; P = 0.04)]. Despite the considerable heterogeneity between studies, the short observation time, and older data, HLA matching improves graft survival in heart transplantation. Prospective HLA-DR matching is clinically feasible and should be considered as a major selection criterion. CI - (c) 2014 Steunstichting ESOT. FAU - Ansari, David AU - Ansari D AD - Division of Cardiothoracic Surgery, Department of Clinical Sciences Lund, Lund University and Skane University Hospital, Lund, Sweden. FAU - Bucin, Dragan AU - Bucin D FAU - Nilsson, Johan AU - Nilsson J LA - eng PT - Journal Article PT - Meta-Analysis PT - Research Support, Non-U.S. Gov't PT - Review PT - Systematic Review DEP - 20140524 PL - Switzerland TA - Transpl Int JT - Transplant international : official journal of the European Society for Organ Transplantation JID - 8908516 RN - 0 (HLA-DR Antigens) SB - IM MH - Graft Survival MH - HLA-DR Antigens/genetics/*immunology MH - *Heart Transplantation/adverse effects/mortality MH - *Histocompatibility Testing MH - Humans MH - Publication Bias MH - Transplantation, Homologous OTO - NOTNLM OT - cardiac allograft vasculopathy OT - graft rejection OT - graft survival OT - heart transplantation OT - human leukocyte antigen OT - outcome OT - patient survival EDAT- 2014/04/15 06:00 MHDA- 2015/05/26 06:00 CRDT- 2014/04/15 06:00 PHST- 2014/02/12 00:00 [received] PHST- 2014/03/16 00:00 [revised] PHST- 2014/04/07 00:00 [accepted] PHST- 2014/04/15 06:00 [entrez] PHST- 2014/04/15 06:00 [pubmed] PHST- 2015/05/26 06:00 [medline] AID - 10.1111/tri.12335 [doi] PST - ppublish SO - Transpl Int. 2014 Aug;27(8):793-804. doi: 10.1111/tri.12335. Epub 2014 May 24.